Merck announces positive results from phase 3 STRI...
Category : Clinical Trial Update 12 September 2025"Merck, known as MSD outside of the United States and Canada, announced positive results from t...
"Merck, known as MSD outside of the United States and Canada, announced positive results from t...
"Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops na...
"Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that two presentations re...
Amgen and Kyowa Kirin announced top-line results from the ASCEND trial, part of the global ROCKET Ph...
Takeda will present new data from its global Phase 3 studies of oveporexton (TAK-861)—a first-...